Phase I study of the antineovascularization drug CM101

Russell F. DeVore, Carl G. Hellerqvist, Gail B. Wakefield, Barbara D. Wamil, Gary B. Thurman, Patricia A. Minton, Håkan W. Sundell, He Ping Yan, Clint E. Carter, Yue Fen Wang, Gerald E. York, Ming Hua Zhang, David H. Johnson

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of the antineovascularization drug CM101'. Together they form a unique fingerprint.

Medicine & Life Sciences